Novel corona virus and the global COVID-19 pandemic have had devastating impacts on financial markets and the economy generally as well as everyday life. All Canadian businesses now face challenges that were unimaginable even a month ago. Canadian corporations that entered 2020 with weak balance sheets and tightening access to capital, however, may find themselves standing at the precipice of difficult decisions.
Canada, Healthcare & Life Sciences, Insolvency & Restructuring, McMillan LLP, Cannabis, Coronavirus, Companies' Creditors Arrangement Act 1933 (Canada)